Back to Agenda
S16 : RMP 2.0 Evolving Pharmaceutical Risk Management with the Revised PMD Act: Toward Patient-Centered Safety - Pharmacovigilance & Labeling -
Session Chair(s)
Mamoru Narukawa, PhD, RPh
Professor, Kitasato University, Japan
Speaker(s)
Kazuya Ichikawa
Assistant Director, Pharmaceutical Safety Division, Pharmaceutical Safety Bureau, Ministry of Health, Labour and Welfare (MHLW), Japan
Masafumi Shimokawa
, Japan
Kazuhiko Ishida, MSc, RPh
Director, Pharmacovigilance, Japan
Makoto Miyazaki, MSc
, Japan Pharmaceutical Manufacturers Association (JPMA) / MSD K.K. , Japan
Nobuhiro Narii, MPharm
Manager, Global Patients Safety Evaluation Japan, , Takeda Pharmaceutical Company Limited, Japan
Have an account?